🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AL2846 is a multi-target receptor tyrosine kinase inhibitor. The purpose of...
Status
Terminated
Location
Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University
Start Date
2021-09-07
Trial ID
NCT05011019
Treatments Being Tested
This is a Phase Ib clinical trial to evaluate the efficacy and safety of AL...
Status
Completed
Location
Affiliated Hospital Of Guilin Medical University
Start Date
2023-02-24
Trial ID
NCT05745363
Treatments Being Tested
This is a study to explore the safety, tolerance and efficacy of AL2846 cap...
Status
Unknown
Location
The First Hospital of China Medical University
Start Date
2020-07-20
Trial ID
NCT04337879
Treatments Being Tested
This is a Phase Ib clinical trial to evaluate the safety and efficacy of TQ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2022-09-02
Trial ID
NCT06116240
Treatments Being Tested
This study aims to demonstrate that, in subjects with locally advanced or m...
Status
Recruiting
Location
The Second Hospital Of Anhui Medical University
Start Date
2025-04-18
Trial ID
NCT06860971
Treatments Being Tested
This is a clinical study to observe the tolerance and primary efficacy of A...
Status
Completed
Location
Tianjin Medical University Cancer Hospital
Start Date
2018-08-23
Trial ID
NCT06278493
Treatments Being Tested
This is a multi-cohort, randomized, open, multicenter Phase II study to eva...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2023-02-15
Trial ID
NCT05815862
Treatments Being Tested
To investigate the efficacy of AL2846 capsules in combination with TQB2450 ...
Status
Unknown
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2023-06-08
Trial ID
NCT05922345
AL2846 is a multi-target tyrosine kinase receptor inhibitor with obvious se...
Status
Unknown
Location
Anhui Chest Hospital
Start Date
2020-09-24
Trial ID
NCT04325776
Treatments Being Tested